IFN-γ can increase PD-L1 expression, including the expression of both full-length and secreted PD-L1 isoforms [40], through enhancing transcription [3], which strengthens the escape of tumor cells from immune surveillance and affects the response of tumor patients to immune checkpoint therapy [40]. Here, IFNG is linked to neoplasm.